| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_298541f9d5da677e241ade3dd77559f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate |
2002-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_615f436c3bb713c905107d8a84a98fa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c911409b9700753276aa4e344e1dea69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7920ad36e7d1729ff2fff489e46487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1a6674b419639e211d9570820b3bb27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd1017e8c9cfaf8abc8cbbfe277f930f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b67adcc6dbaff5780ae9b16f505b1b8 |
| publicationDate |
2010-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2333413-T3 |
| titleOfInvention |
A METHOD FOR PRODUCING GLP-1 POLYPEPTIDE (7-36) INSULINOTROPIC AND / OR ANALOGS OF GPL-1. |
| abstract |
A method for producing insulinotropic GLP-1 (7-36) polypeptide and / or GLP-1 analogs consisting of: (a) Introducing two points with restrictive individual endonuclease cleavage capable of forming a hybrid point at the two terminals of the gene which can encode the GLP-1 polypeptide (7-36) and / or GLP-1 analogs; (b) Bind the cohesive ends to form a hybrid point after digestion with the restrictive endonucleases, and clone in a vector N copies of the GLP-1 gene (7-36) attached to the series, GLP-1 analogue gene, or interactively linked genes encoding the GLP-1 polypeptide (7-36) or GLP-1 analogs, where N is an integer between 2 and 32; (c) Transform the vector containing the gene bound to the series into a host cell. (d) Express in the host cell a fusion protein containing N copies of a polypeptide where N is an integer between 2 and 32, said fusion protein containing the GLP-1 polypeptide (7-36), GLP-analogs 1 or the combination thereof, but without any carrier protein; (e) Split the fusion protein; (f) Separate and purify GLP-1 polypeptides (7-36) and / or GLP-1 analogs. |
| priorityDate |
2001-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |